KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) EPS (Basic) (2016 - 2025)

Edwards Lifesciences has reported EPS (Basic) over the past 17 years, most recently at $0.13 for Q4 2025.

  • Quarterly results put EPS (Basic) at $0.13 for Q4 2025, down 77.59% from a year ago — trailing twelve months through Dec 2025 was $1.82 (down 22.22% YoY), and the annual figure for FY2025 was $1.81, down 74.07%.
  • EPS (Basic) for Q4 2025 was $0.13 at Edwards Lifesciences, down from $0.5 in the prior quarter.
  • Over the last five years, EPS (Basic) for EW hit a ceiling of $0.79 in Q2 2021 and a floor of $0.13 in Q4 2025.
  • Median EPS (Basic) over the past 5 years was $0.55 (2021), compared with a mean of $0.56.
  • Biggest five-year swings in EPS (Basic): surged 495.0% in 2021 and later tumbled 77.59% in 2025.
  • Edwards Lifesciences' EPS (Basic) stood at $0.54 in 2021, then grew by 20.37% to $0.65 in 2022, then fell by 15.38% to $0.55 in 2023, then grew by 5.45% to $0.58 in 2024, then tumbled by 77.59% to $0.13 in 2025.
  • The last three reported values for EPS (Basic) were $0.13 (Q4 2025), $0.5 (Q3 2025), and $0.58 (Q2 2025) per Business Quant data.